← Back to Dashboard

LAURUSLABS Laurus Labs Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare
₹ 1,840.00
-1.53%
1-year price · range ₹832–₹1,915

Live setups screens LAURUSLABS is on right now — tap to see every stock matching

Smart Money Verdict synthesis of derivatives, deals, and promoter files

Derivatives signal Short Covering
Price rose (+0.4%) on short-covering (OI down -1.2%), suggesting a temporary relief bounce rather than new buyers.

Analysis what the data is telling us about LAURUSLABS

In the last completed session, Laurus Labs Ltd. closed +0.40% with futures open interest moving -1.2%. That combination — price rising while OI shrinks — is classified as Short Covering. It typically reflects existing short sellers closing positions, not fresh buying. Short-covering rallies can be sharp but tend to fade without follow-through demand. The stock's option PCR sits at 0.63, indicating heavy call-side writing — option dealers see resistance overhead.

On the institutional side, FIIs have been unwinding Laurus Labs Ltd. — the most recent notable was BNP PARIBAS FINANCIAL MARKETS on the sell side at ₹1,201 Cr.

Putting it together, the smart-money picture for Laurus Labs Ltd. suggests upside momentum is building.

F&O Positioning EOD derivatives setup

Buildup Class
Short Covering
bias: bullish
Futures OI
19,534,700
-235450 (-1.2%)
Option PCR (OI)
0.63
heavy call writing
Max Pain Strike
₹ 1,840
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 1,868.50
yesterday's EOD close
Index Contribution
not a Nifty 50 constituent
Traded Volume
1,075,943
live shares traded today
Upcoming Earnings
no report scheduled

Technical Snapshot from 400 sessions of price history

RSI (14)
54.2
neutral momentum
52-Week High
₹ 1,949.00
-5.6% from high
52-Week Low
₹ 823.10
+123.5% above low
200-DMA
₹ 1,271.73
+44.7% · above trend
50-DMA
₹ 1,716.18
+7.2% from 50-DMA
1-Year Return
+110.4%
1M +0.5%

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
91.2
price / earnings
P/B
18.7
price / book
ROE
return on equity
Market Cap
₹ 99,417 Cr
total market value
Dividend Yield
0.13%
trailing yield
EPS (TTM)
₹ 20.18
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

Date Side Price Value (Cr) Counterparty
2026-08-31 SELL ₹ 1,914.28 1,200.67 BNP PARIBAS FINANCIAL MARKETS FII
2026-08-31 SELL ₹ 1,914.04 982.74 INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.
2026-08-31 SELL ₹ 1,903.84 535.06 SOCIETE GENERALE FII

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-09-29 · spot 1,868 · EOD 2026-09-03

Option writers expect range between 1,800 and 1,900+1.7% upside, -3.7% downside.
downside-skewed
Call OI (writers) Strike Put OI (writers)
22,100
1740
309,400 -28k
IV 25% Δ -0.12 θ -0.5 ν 1
35,700
1760
248,200 -12k
IV 25% Δ -0.15 θ -0.5 ν 1
39,950
1780
221,000 -1k
IV 24% Δ -0.19 θ -0.6 ν 1
741,200 -21k
IV 21% Δ 0.78 θ -0.9 ν 1
1800 S
835,550 +36k
IV 24% Δ -0.24 θ -0.7 ν 2
307,700 -8k
IV 20% Δ 0.73 θ -0.9 ν 2
1820
618,800 -17k
IV 24% Δ -0.30 θ -0.7 ν 2
686,800 -57k
IV 21% Δ 0.65 θ -1.0 ν 2
1840 MP
681,700 +6k
IV 24% Δ -0.36 θ -0.8 ν 2
743,750 +52k
IV 22% Δ 0.57 θ -1.0 ν 2
1860
787,950 +43k
IV 24% Δ -0.43 θ -0.8 ν 2
1,201,900 +12k
IV 22% Δ 0.50 θ -1.0 ν 2
1880
497,250 +53k
IV 24% Δ -0.50 θ -0.8 ν 2
1,470,500 -79k
IV 22% Δ 0.43 θ -1.0 ν 2
1900 R
572,050 +10k
IV 25% Δ -0.56 θ -0.8 ν 2
596,700 +23k
IV 22% Δ 0.36 θ -0.9 ν 2
1920
162,350 +2k
IV 24% Δ -0.63 θ -0.7 ν 2
932,450 +37k
IV 23% Δ 0.30 θ -0.9 ν 2
1940
90,950
IV 29% Δ -0.65 θ -0.8 ν 2
338,300 -5k
IV 23% Δ 0.25 θ -0.8 ν 2
1960
80,750 +4k
IV 23% Δ -0.76 θ -0.4 ν 2
215,050 +11k
IV 24% Δ 0.20 θ -0.7 ν 1
1980
850
IV 67% Δ -0.59 θ -2.3 ν 2

Chain Interpretation

Spot Underlying 1,868.50
Key Resistance (R) 1,900
Key Support (S) 1,800
Max Pain Strike (MP) 1,840
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for LAURUSLABS options · 2026-09-29 expiry

Underlying: LAURUSLABS · Spot: ₹ 1,868.50 · Expiry: 2026-09-29 · Lot: 850

Legs

Side
Type
Strike
Qty
Premium
Net premium
Max profit
Max loss
Breakevens
Position Delta
Position Theta/day
Position Vega/1% IV

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others

LAURUSLABS — frequently asked questions

What is the Laurus Labs Ltd. share price today?

LAURUSLABS is trading at ₹1,840.00 (-1.53% vs previous close), per the latest update on this page.

What is the P/E ratio of Laurus Labs Ltd.?

LAURUSLABS (Laurus Labs Ltd.) has a trailing twelve-month P/E ratio of 91.2.

What is the market cap of Laurus Labs Ltd.?

LAURUSLABS has a market capitalisation of approximately ₹99,417 crore.

Is LAURUSLABS near its 52-week high?

LAURUSLABS is trading -5.6% from its 52-week high of ₹1,949.00 as of 2026-09-04.

What is the RSI of LAURUSLABS?

The 14-day RSI of LAURUSLABS is 54.2, which is considered neutral.

Is LAURUSLABS above its 200-day moving average?

LAURUSLABS is trading above its 200-DMA of ₹1,271.73 (+44.7% away).

What is the F&O buildup in LAURUSLABS?

The latest end-of-day derivatives data classifies LAURUSLABS as Short Covering (bias: bullish), based on the day's combined price and open-interest change.

What is the max pain and PCR for LAURUSLABS options?

LAURUSLABS's option-chain max pain strike is ₹1,840 and its put-call ratio (OI) is 0.63, from the latest end-of-day option chain.

Are FIIs or big investors buying LAURUSLABS?

Strota tracks every bulk and block deal in LAURUSLABS with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.